gvtcx

PS26060 - Mapping Regulatory Landscape for Genetically Modified Medicines

DSIT Published 20 Aug 2026 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£49,550
Statuscomplete
Category (CPV) 73000000 +1 more
Deadline22 Jun 2026
Contract start10 Aug 2026
Contract end10 Feb 2027
Procedureselective
SME suitableYes
OCIDocds-b5fd17-00bebff2-f5f4-4e92-8be0-f907a16e74ba

Award

SupplierValueDateStatus
Technopolis Limited £49,550 23 Jul 2026 active

description

***** THIS IS AN AWARD NOTICE, NOT A CALL FOR COMPETITION *****

This contract has been awarded on CCS Research & Insights DPS RM6126.

Description

This procurement covers the provision of specialist services to undertake a regulatory mapping exercise for engineered bacterial therapeutics in the UK. Example companies working in this space include Prokarium, Neobe Tx, CHAIN Biotech.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
20 Aug 2026 Award (award) · 94b205eb-226a-4840-8262-12897fed950c-911440

more from DSIT

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.